Greg Bell – CEO
Morgan Prestwich serves life science clients globally, and specialise in USA, EU, Middle East and APAC regions. We have placed in 27 countries to date.
We aim to shortlist within 2-3 weeks, with process completion and under offer between 6-8 weeks.
Our clients choose us time and time again, proving to us that we offer something more than other search firms.
Spoken fluently across our staff including German, French, Italian, Spanish, Swedish, Dutch, Portuguese and Cantonese to name a few.
After 12 months, 98% of our placements were still situated and happy in new position.
In 2022 60% of our placements where diverse, a figure we aim to at least maintain in 2023.
Highly trained search consultants.
We pride ourselves on having never failed in filling a retained project, our 100% placement success is down to our profound knowledge and expertise in guiding clients to the right candidates and vice versa.
With a full understanding of the role, the ideal candidate is identified and a comprehensive brief agreed.
Following investigative desk and database research, we target & approach skilled global candidates.
Longlisted candidates are interviewed and assessed on technical skills, company fit, motivations, aspirations, achievements and remuneration levels.
A shortlist is agreed.
Executive summaries, assessments and resumes are presented for highly suitable candidates.
Psychometric tests are also offered, if preferred, via an external partner.
Formal panel interviews, assessments and psychometric testing take place.
Once a preferred candidate is identified, we broker offer negotiations and, if required, will complete final referencing.
Unsuccessful candidates are managed with professionalism with your reputation protected.
Offer is made with due diligence, referencing and verification.
On-boarding and support are provided to both candidate and client.
Feedback is recorded.
Morgan Prestwich is committed to providing the best service possible by educating all our staff on how they can improve hiring practices and create a diverse working environment. The entire team are trained in:
- Unconscious bias candidate interviewing and shortlisting.
- Influencing cultural diversity into a client’s talent hiring process.
- The benefits of diverse companies.
We believe that a company's success is only achieved through the diverse talents they employ. We are committed to expanding your company's workforce by helping you find the diverse, top talent needed for you to thrive.
"One of the elements that stands out with Morgan Prestwich is their ability to quickly understand our requirements, the team fit and importantly provide constructive discussion on the suitability of the candidates - understanding of our individual leaders’ styles and the ethos/culture of our team and company. Importantly, they also have a strong reputation with the candidates – and a strong understanding market dynamics, important when acting as a credible interface with our business. Morgan Prestwich’s team has proven to be efficient, nimble, successful and engaging for the build of our INTL team - and I would happily recommend their services to a prospective client.”
Steve Arnold - President International Albireo
"Touchlight started working with Morgan Prestwich two years ago to recruit a CFO and Head of HR. Prior to this we had filled all our senior positions directly. We liked the approach taken by Greg and his team: thoughtful, discreet, with a considered understanding of our company and requirement. The proof is that we are thrilled with our CFO and Head of HR and have worked with Greg on many other briefs since." Jonny Ohlson - Chairman & CEO Touchlight Genetics
“We are constantly reminded just how important getting human capital right is to our ventures. Greg’s and the wider Morgan Prestwich team have consistently been an essential partner to us as we build management teams for our portfolio companies. They are also available to consult as we monitor the decisions we make, providing invaluable input.”
Dr William Garner - Founder EGB Ventures, Tryp Therapeutics, Race Oncology, GeneTether, Chairman InsMed